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SUMMARY:	33 
Microglia,	the	resident	immune	cells	of	the	brain,	respond	quickly	with	morphological	changes	to	34 
modifications	of	their	environment.	This	protocol	describes	how	to	use	two-photon	microscopy	35 
to	study	the	attraction	of	microglial	processes	toward	serotonin	or	ATP	in	acute	brain	slices	of	36 
mice.		37 
	38 
ABSTRACT:	39 
Microglial	 cells	 are	 resident	 innate	 immune	 cells	 of	 the	 brain	 that	 constantly	 scan	 their	40 
environment	 with	 their	 long	 processes	 and,	 upon	 disruption	 of	 homeostasis,	 undergo	 rapid	41 
morphological	changes.	For	example,	a	laser	lesion	induces	in	a	few	minutes	an	oriented	growth	42 
of	microglial	processes,	also	called	“directional	motility”,	toward	the	site	of	injury.	A	similar	effect	43 
can	 be	 obtained	 by	 delivering	 locally	 ATP	 or	 serotonin	 (5-hydroxytryptamine	 [5-HT]).	 In	 this	44 
	 	
article,	we	describe	a	protocol	to	induce	a	directional	growth	of	microglial	processes	toward	a	45 
local	application	of	ATP	or	5-HT	in	acute	brain	slices	of	young	and	adult	mice	and	to	image	this	46 
attraction	over	time	by	multiphoton	microscopy.	A	simple	method	of	quantification	with	free	and	47 
open-source	image	analysis	software	is	proposed.	A	challenge	that	still	characterizes	acute	brain	48 
slices	is	the	limited	time,	decreasing	with	age,	during	which	the	cells	remain	in	a	physiological	49 
state.	This	protocol,	thus,	highlights	some	technical	improvements	(medium,	air-liquid	interface	50 
chamber,	imaging	chamber	with	a	double	perfusion)	aimed	at	optimizing	the	viability	of	microglial	51 
cells	over	several	hours,	especially	in	slices	from	adult	mice.		52 
	53 
INTRODUCTION:	54 
Microglial	cells	are	the	brain’s	resident	macrophages	and	play	a	role	 in	both	physiological	and	55 
pathological	conditions1,2.	They	have	a	highly	branched	morphology	and	are	constantly	extending	56 
and	retracting	their	processes3,4.	This	“scanning”	behavior	is	believed	to	be	related	and	necessary	57 
to	the	survey	of	their	surroundings.	The	morphological	plasticity	of	microglia	is	expressed	in	three	58 
modes.	First,	some	compounds	rapidly	modulate	microglial	morphology:	the	addition	of	ATP5,6	or	59 
NMDA5,7	 in	 the	 medium	 bathing	 acute	 brain	 slices	 increases	 the	 complexity	 of	 microglial	60 
ramifications,	whereas	norepinephrine	decreases	it6.	These	effects	either	are	directly	mediated	61 
by	microglial	receptors	(for	ATP	and	norepinephrine)	or	require	an	ATP	release	from	neurons	(for	62 
NMDA).	 Second,	 the	 growth	 and	 retraction	 speed	 of	 microglial	 processes,	 called	 motility	 or	63 
“surveillance”,	 can	 be	 affected	 by	 extracellular	 factors8,	 homeostasis	 disruptions9,10,	 or	64 
mutations9-11.	Third,	in	addition	to	these	isotropic	changes	of	morphology	and	motility,	microglia	65 
have	the	capacity	to	extend	their	processes	directionally	toward	a	pipette	delivering	ATP3,5,12-14,	66 
in	culture,	in	acute	brain	slices	or	in	vivo,	or	delivering	5-HT	in	acute	brain	slices15.	Such	oriented	67 
growth	of	microglial	processes,	also	called	directional	motility,	was	first	described	as	a	response	68 
to	 a	 local	 laser	 lesion3,4.	 Thus,	 physiologically,	 it	may	 be	 related	 to	 the	 response	 to	 injury	 or	69 
required	for	targeting	microglial	processes	toward	synapses	or	brain	regions	requiring	pruning	70 
during	development15,16,	or	in	physiological17-19	or	pathological	situations9,18-20	in	adulthood.	The	71 
three	types	of	morphological	changes	rely	on	different	intracellular	mechanisms11,13,20,	and	one	72 
given	compound	does	not	necessarily	modulate	all	of	them	(e.g.,	NMDA,	which	acts	indirectly	on	73 
microglia,	has	an	effect	on	morphology	but	does	not	 induce	directional	motility5,7).	Therefore,	74 
when	aiming	to	characterize	the	effect	of	a	compound,	a	mutation	or	a	pathology	on	microglia,	it	75 
is	 important	 to	 characterize	 the	 three	components	of	 their	morphological	plasticity.	Here,	we	76 
describe	a	method	to	study	the	directional	growth	of	microglial	processes	toward	a	local	source	77 
of	compound,	which	is,	here,	ATP	or	5-HT.		78 
	79 
There	 are	 several	 models	 to	 study	 microglia	 processes’	 attraction:	 primary	 cultures	 in	 3D	80 
environment6,18,19,	acute	brain	slices6,13,15,	and	in	vivo	imaging3,13.	The	in	vivo	approach	is	the	best	81 
to	 preserve	 the	 physiological	 state	 of	 microglia.	 However,	 intravital	 imaging	 of	 deep	 regions	82 
requires	 complex	 surgical	 procedures	 and,	 therefore,	 it	 is	 often	 limited	 to	 superficial	 cortical	83 
layers.	The	use	of	microglia	primary	culture	 is	the	easiest	technique	to	test	a	 large	number	of	84 
conditions	with	a	limited	number	of	animals.	Nevertheless,	it	is	impossible	to	obtain	the	same	85 
cell	 morphology	 as	 in	 vivo,	 and	 cells	 lose	 their	 physiological	 interactions	 with	 neurons	 and	86 
astrocytes.	 Acute	 brain	 slices	 represent	 a	 compromise	 between	 these	 two	 approaches.	 This	87 
model	allows	researchers	to	study	brain	structures	which	are	otherwise	difficult	to	reach	and	to	88 
	 	
image	 with	 high	 resolution	 in	 vivo,	 and	 to	 investigate	 slices	 from	 neonatal	 stages,	 whereas	89 
transcranial	microscopy	is	mostly	performed	at	adulthood.	Finally,	it	makes	it	possible	to	observe	90 
in	real-time	the	effects	of	local	drug	application,	and	to	repeat	experiments	while	using	a	limited	91 
number	of	animals.	Nonetheless,	an	issue	with	acute	brain	slices	is	the	limited	time	(a	few	hours)	92 
during	which	the	cells	remain	alive,	notably	for	slices	from	mice	older	than	two	weeks,	and	the	93 
potential	change	of	microglia	morphology	over	time21,22.	94 
	95 
Here,	we	describe	a	protocol	to	prepare	acute	brain	slices	of	young	and	adult	Cx3cr1GFP/+	mice	up	96 
to	two	months	old,	with	the	preservation	of	microglia	morphology	and	motility	for	several	hours.	97 
We,	then,	describe	how	to	use	these	slices	to	study	the	attraction	of	microglial	processes	toward	98 
compounds	like	ATP	or	5-HT.		99 
	100 
PROTOCOL:	101 
All	experiments	were	approved	by	the	local	ethical	committee	(Darwin	Committee,	agreements	102 
#1170	and	#10921).	103 
	104 
1. Preparation	of	Glass	Micropipettes	for	the	Local	Application	of	Compounds	105 
	106 
1.1. Prepare	pipettes	from	borosilicate	thin-wall	glass	capillaries	with	an	electrode	puller.	Adjust	107 
the	parameters	to	obtain	pipettes	with	a	4	-	5	µm	diameter	at	their	extremity.	Figure	2D	shows	108 
one	pipette	in	brightfield	at	low	magnification.		109 
	110 
2. Solutions	111 
	112 
2.1. Ensure	that	only	glassware	that	has	been	cleaned	by	an	autoclave	cycle,	followed	by	rinsing	113 
2x	 -	3x	with	ultrapure	water,	will	be	used.	Never	use	glassware	that	has	been	 in	contact	with	114 
paraformaldehyde.	115 
	116 
2.2. Prepare	a	2	mol·L-1	CaCl2	stock	solution	by	dissolving	14.7	mg	of	CaCl2·2H2O	in	50	mL	of	water	117 
of	high	purity	(ultrapure	water,	resistance	18.2	MΩ;	the	traces	of	metal	in	distilled	water	or	tap	118 
water	can	lead	to	suboptimal	slice	quality	due	to	pro-oxidative	effects).	119 
	120 
2.2.1. Store	this	stock	solution	at	room	temperature	for	a	maximum	of	one	month.	121 
	122 
2.3. On	 the	 day	 of	 the	 experiment,	 prepare	 1	 L	 of	 choline-aCSF	 (artificial	 cerebrospinal	 fluid)	123 
solution,	 whose	 composition	 is	 110	 mmol·L-1	 choline	 Cl,	 25	 mmol·L-1	 glucose,	 25	 mmol·L-1	124 
NaHCO3,	 7	 mmol·L-1	 MgCl2,	 11.6	 mmol·L-1	 ascorbic	 acid,	 3.1	 mmol·L-1	 sodium	 pyruvate,	 2.5	125 
mmol·L-1	KCl,	1.25	mmol·L-1	NaH2PO4,	and	0.5	mmol·L-1	CaCl2,	0.5.	126 
	127 
2.3.1. To	prepare	this	solution,	add,	in	the	following	order,	to	a	1	L	graduated	flask:	0.186	g	of	KCl,	128 
0.195	g	of	NaH2PO4,	2.04	g	of	acid	ascorbic,	2.1	g	of	NaHCO3,	and	4.5	g	of	glucose.	129 
	130 
2.3.2. Fill	about	half	of	the	final	volume	with	ultrapure	water	and	stir	until	complete	dissolution.	131 
	132 
	 	
2.3.3. Add	0.34	g	of	sodium	pyruvate	and	15.36	g	of	choline	Cl.	133 
	134 
NOTE:	It	is	convenient	to	first	dissolve	the	choline	Cl	with	5	to	10	mL	of	the	solution	prepared	in	135 
step	2.3.2	before	adding	it	to	the	whole	solution.	136 
	137 
2.3.4. Add	7	mL	of	1	mol·L-1	MgCl2	and	250	µL	of	2	mol·L-1	CaCl2	(prepared	 in	step	2.2)	 to	the	138 
solution.		139 
	140 
2.3.5. Fill	the	graduated	flask	up	to	1	L	with	ultrapure	water.	141 
	142 
2.3.6. With	a	vapor	pressure	osmometer,	check	that	the	osmolarity	is	between	300	and	310	mΩ.	143 
If	not,	adjust	it	with	glucose.		144 
	145 
2.3.7. Check	the	pH	after	carbogenation	(i.e.,	bubbling	with	“carbogen”,	a	mix	of	95%	O2/5%	CO2)	146 
and	adjust	it,	if	necessary,	to	7.3	-	7.4	with	10	M	NaOH.	147 
	148 
2.3.8. Transfer	the	solution	to	a	glass	bottle	for	storage.	Keep	the	bottle	in	the	fridge	until	use	149 
(STEP	3.1).	150 
	151 
NOTE:	 It	 is	 recommended	to	make	a	 fresh	solution	on	the	day	of	 the	experiment.	However,	 if	152 
necessary,	choline-aCSF	can	be	stored	up	to	two	days	at	4	°C.	153 
	154 
2.4. On	the	day	of	the	experiment,	prepare	1	L	of	an	aCSF	solution,	whose	composition	is	124	155 
mmol·L-1	NaCl,	26.2	mmol·L-1	NaHCO3,	25	mmol·L-1	glucose,	2.5	mmol·L-1	KCl,	2	mmol·L-1	CaCl2,	1	156 
mmol·L-1	MgCl2,	and	1.25	mmol·L-1	NaH2PO4.		157 
	158 
2.4.1. To	 prepare	 this	 solution,	 add,	 in	 the	 following	 order,	 to	 a	 graduated	 flask:	 0.150	 g	 of	159 
NaH2PO4,	0.186	g	of	KCl,	2.2	g	of	NaHCO3,	4.5	g	of	glucose,	and	7.3	g	of	NaCl.	Bring	the	solution	160 
to	a	volume	of	1	L	with	ultrapure	water	and	stir	it	vigorously	on	a	stir	plate.	161 
	162 
2.4.2. Add	1	mL	of	1	mol·L-1	MgCl2	and	1	mL	of	2	mol·L-1	CaCl2	to	the	solution	and	transfer	the	163 
aCSF	solution	to	a	glass	bottle	for	storage.	164 
	165 
2.4.3. Check	whether	the	osmolarity	is	300	-	310	mΩ·L-1	and,	if	not,	adjust	it	with	glucose.		166 
	167 
2.4.4. Check	 the	 pH	 after	 carbogenation	 (i.e.,	 bubbling	 with	 “carbogen”)	 and	 adjust	 it,	 if	168 
necessary,	to	7.3	-	7.4	with	10	M	NaOH.	169 
	170 
2.4.5. Transfer	the	solution	to	a	glass	bottle	for	storage.	Keep	the	bottle	in	the	fridge	until	use	171 
(step	3.1).	172 
	173 
NOTE:	It	is	recommended	to	make	a	fresh	solution	on	the	day	of	the	experiment.	However,	an	174 
alternative	is	to	prepare	a	10x	stock	solution	containing	NaCl,	NaHCO3,	KCl,	and	NaH2PO4	at	10x	175 
the	final	concentration,	which	can	be	stored	for	no	more	than	one	week	at	4	°C.	Make	the	final	176 
	 	
aCSF	on	the	day	of	the	experiment	by	diluting	the	10x	stock	solution	with	ultrapure	water	and	177 
adding	the	glucose,	CaCl2,	and	MgCl2.	178 
	179 
2.5. Prepare	the	drug	solutions	on	the	day	of	the	experiment.	Use	the	aCSF	solution	to	bring	them	180 
to	the	final	concentrations	which	are,	here,	500	µmol·L-1	for	ATP	and	5	µmol·L-1	for	5-HT.	181 
	182 
NOTE:	For	ATP,	a	stock	solution	can	be	prepared	(e.g.,	50	mM	ATP	in	water),	stored	in	aliquoted	183 
form	at	-20	°C,	and	diluted	with	aCSF	to	the	final	concentration	on	the	day	of	the	experiment.	In	184 
contrast,	 the	5-HT	 (serotonin-HCl)	 solution	must	be	prepared	 from	powder	on	 the	day	of	 the	185 
experiment,	at	1	mg·mL-1	in	water,	kept	at	4	°C	to	avoid	5-HT	oxidation,	and	diluted	in	aCSF	at	the	186 
time	of	the	experiment.	187 
	188 
3. Preparation	of	Acute	Brain	Slices	189 
	190 
3.1. Preparation	of	the	dissection	area	191 
	192 
3.1.1. Prepare	70	mL	of	ice-cold	choline-aCSF	in	an	80	mL	beaker	placed	on	ice,	to	be	used	for	193 
cardiac	perfusion,	rapid	cooling	down	of	the	brain,	and	slicing.	Prepare	150	mL	of	choline-aCSF	in	194 
a	200	mL	crystallizing	dish,	placed	in	a	heated	water	bath	maintained	at	32	°C.	Place	a	nylon	mesh	195 
strainer	in	the	crystallizing	dish	to	retain	the	slices.	This	will	be	used	to	let	the	slices	recover	for	196 
10	min	just	after	slicing.	197 
	198 
3.1.2. At	 least	 30	 min	 before	 starting	 the	 dissection	 (section	 3.2),	 start	 bubbling	 these	 two	199 
solutions	 (70	mL	of	 choline-aCSF	on	 ice	and	150	mL	of	 choline-aCSF	at	32°	C)	with	carbogen.	200 
Maintain	constant	carbogenation	during	the	entire	procedure.	201 
	202 
3.1.3. Prepare	the	interface	chamber	device	(Figure	1C),	which	will	be	used	to	keep	slices	until	203 
their	use.	204 
	205 
3.1.3.1. In	a	sealed	food	box	(10	x	10	cm	or	10	cm	in	diameter,	8	cm	in	height),	 installed	on	a	206 
magnetic	stirrer,	place	a	200	mL	crystallizing	dish	with	a	bar	magnet.		207 
	208 
3.1.3.2. Add	 200	mL	 of	 aCSF	 in	 this	 crystallizing	 dish	 and	 place	 the	 3D-printed	 interface	 slice	209 
holder	on	top	of	it	(the	interface	slice	holder	is	composed	of	two	perfectly	fitting	parts,	with	a	210 
polyamide	mesh	stretched	between	them,	Figure	1A,B).		211 
	212 
3.1.3.3. Remove	excess	volume	 from	 the	crystallizing	dish	 to	keep	only	a	 thin	 film	of	 solution	213 
covering	 the	 mesh	 of	 the	 interface	 slice	 holder.	 This	 will	 later	 create	 a	 fine	 rim	 of	 solution	214 
surrounding	the	slices	(but	without	covering	them).		215 
	216 
3.1.3.4. Put	a	few	millimeters	of	aCSF	at	the	bottom	of	the	food	box	and	start	bubbling	it	with	217 
carbogen	(at	first	use,	make	a	small	hole	in	the	sealed	food	box	wall	to	make	sure	the	tubing	can	218 
enter	the	box).	219 
	220 
	 	
3.1.3.5. Close	 the	 sealed	 box	 while	 maintaining	 constant	 carbogenation.	 This	 will	 create	 a	221 
humidified	95%	O2/5%	CO2	rich	environment	 in	which	the	slices	will	be	 transferred	after	 their	222 
recovery	in	choline-aCSF	and	maintained	before	they	are	imaged.	This	device	is	hereafter	referred	223 
to	as	the	“interface	chamber”	(Figure	1C).	224 
	225 
3.2. Brain	dissection	and	slicing	226 
	227 
3.2.1. Anesthetize	the	mouse	with	an	intraperitoneal	injection	of	50	mg·mL-1	pentobarbital	(0.15	228 
mL	/20	g	of	mouse	body	weight),	immobilize	it,	expose	the	heart,	and	perform	a	cardiac	perfusion	229 
with	 10	mL	 of	 ice-cold,	 carbogenated,	 choline-aCSF	 (see	 step	 3.1.1),	with	 a	 peristaltic	 pump.	230 
Observe	the	pallor	of	the	liver	as	an	indicator	of	a	good	perfusion.	The	perfusion	lasts	less	than	5	231 
min.		232 
	233 
3.2.2. Decapitate	the	mouse	and	cut	the	skin	to	expose	the	skull.	With	big	scissors,	apply	two	234 
transversal	cuts	from	the	large	foramen	and	one	long	sagittal	cut	and,	using	fine	forceps,	remove	235 
the	skull	plates.	236 
	237 
3.2.3. Quickly	and	gently	extract	the	brain	(in	less	than	1	min)	and	place	it	for	1	min	in	the	80	mL	238 
beaker	 containing	 the	 remaining	 (~60	 mL)	 ice-cold	 choline-aCSF	 (still	 under	 constant	239 
carbogenation),	in	order	to	cool	it	down.	240 
	241 
3.2.4. Transfer	the	brain	onto	a	filter	paper	previously	wet	with	aCSF.	242 
	243 
3.2.5. Cut	out	the	brain	according	to	the	brain	region	of	interest	and	preferred	angle	of	slicing.	244 
For	example,	to	image	the	thalamus	or	the	hippocampus	on	coronal	slices,	cut	out	with	a	scalpel	245 
blade	the	cerebellum	and,	then,	about	2	mm	from	the	rostral	and	caudal	extremities	of	the	brain.	246 
	247 
NOTE:	It	is	important	to	remove	brain	parts	that	are	too	rostral	or	too	caudal	because	the	smaller	248 
the	region	to	trim	before	reaching	the	area	of	interest,	the	faster	the	slicing.	A	total	time	for	slicing	249 
(step	3.2.7)	of	less	than	20	min	is	recommended.	250 
	251 
3.2.6. For	coronal	slices,	position	and	glue	(with	cyanoacrylate	glue)	the	caudal	face	of	the	brain	252 
onto	 a	 10	 cm	Petri	 dish,	 glued	on	 the	 cutting	block	 and	 filled	with	 all	 the	 remaining	 ice-cold	253 
choline-aCSF.	The	block	with	the	dish	is,	then,	positioned	in	the	reservoir	chamber	of	the	vibrating	254 
slicer,	which	is	positioned	in	a	larger	chamber	filled	with	ice.	255 
	256 
3.2.7. While	keeping	constant	the	95%	O2/5%	CO2	bubbling	of	the	ice-cold	choline-aCSF,	cut	300	257 
µm-thick	coronal	slices	(speed:	0.08	mm·s-1,	blade	vibration:	60	Hz,	vibration	amplitude:	1	mm).	258 
	259 
3.2.8. Collect	the	brain	slices	with	a	wide-mouth	(4	mm	in	diameter)	disposable	transfer	pipette,	260 
one	by	one	after	every	single	pass	of	the	blade,	to	avoid	the	accumulation	of	toxic	components	261 
released	by	the	periphery	of	the	slices.	Take	care	to	avoid	air	bubbles	during	the	transfer	and	262 
place	each	slice	in	the	choline-aCSF	at	32	°C	for	about	10	min	for	recovery.	263 
	264 
	 	
3.2.9. With	the	transfer	pipette,	place	the	slices	onto	pieces	of	lens-cleaning	paper	topped	with	265 
a	drop	of	choline-aCSF.	Aspirate	the	excess	of	choline-aCSF	and,	with	the	spatula,	place	the	slices,	266 
laid	on	the	lens-cleaning	tissue,	on	the	mesh	of	the	interface	chamber	containing	carbogenated	267 
aCSF	at	room	temperature	(see	3.1.3.5).	Let	the	slice	recover	in	this	environment	for	at	least	30	268 
min.		269 
	270 
NOTE:	After	this,	the	slices	are	ready	and	can	be	used	for	microglia	imaging	for	up	to	6	h	after	the	271 
brain	 extraction	 from	 young	 (less	 than	 one-month-old)	 mice	 and	 up	 to	 4	 h	 after	 the	 brain	272 
extraction	from	two-months-old	adults.	273 
	274 
4. Two-photon	Microscopy	275 
	276 
4.1. Parameters	setting	277 
	278 
4.1.1. Switch	 on	 the	 multiphoton	 system	 (hybrid	 detectors,	 laser,	 scanner,	 electro-optic	279 
modulator,	microscope).	280 
	281 
4.1.2. Tune	the	laser	at	920	nm,	check	that	the	laser	is	mode-locked,	and	set	the	power	at	5%	-	282 
15%	and	the	gain	at	10%.	This	corresponds	to	a	power	of	3	-	5	mW	under	the	objective.	Ensure	283 
that	the	nondescanned	detectors	are	engaged	and	the	appropriate	emission	and	excitation	filters	284 
installed.		285 
	286 
4.1.3. 	Set	parameters	of	the	imaging	software	to	the	following	values:	for	the	frame	size,	1024	x	287 
1024	pixels	corresponding	to	an	area	of	295.07	x	295.07	µm;	for	the	zoom,	2.	If	the	signal	is	very	288 
noisy,	apply	a	 line	average	of	2.	For	the	pixel	dynamics,	set	the	imaging	software	at	12	bits	or	289 
more.		290 
	291 
NOTE:	 Images	 with	 a	 higher	 bit	 value	 allow	 researchers	 to	 distinguish	 smaller	 differences	 in	292 
fluorescence	intensity	than	images	with	a	lower	bit	value:	a	change	of	one	gray	value	in	an	8-bit	293 
image	would	correspond	to	a	change	of	16	gray	values	in	a	12-bit	and	of	256	gray	values	in	a	16-294 
bit	image.	Therefore,	higher-bit	images	are	more	appropriate	for	quantitative	analysis,	but	as	their	295 
size	increases	with	bit	depth,	storage	capacity,	and	computing	power	can	become	limiting.	296 
	297 
4.1.4. Select	the	scan	mode	XYZT	with	a	Z-interval	range	at	2	µm	and	a	T-interval	of	2	min.	298 
	299 
NOTE:	The	x,y	and	z	resolution	are	determined	by	the	Nyquist	sampling	theorem.	A	Z-step	size	300 
around	0.8	would	be	optimal	to	resolve	microglia	processes	(with	a	diameter	of	<1	µm),	but	the	301 
optical	resolution	of	multiphoton	microscopy	is	limiting	(at	920	nm	with	a	0.95	NA	objective,	the	302 
axial	resolution	is	around	1	µm).	On	top	of	that	physical	barrier,	in	a	live-imaging	experiment,	the	303 
sensitivity	 or	 signal-to-noise	 ratio,	 the	 resolution,	 the	 speed,	 and	 the	 total	 observation	 time	304 
matter.	Taking	into	account	all	these	parameters,	a	z-step	of	2	µm	(as	in	numerous	studies3,11,14),	305 
an	 image	 size	 of	 1024	 x	 1024	 pixels,	 and	 a	 high-speed	 acquisition	 using	 a	 resonant	 scanner	306 
coupled	to	HyD	detectors	(it	takes	around	15	s	to	acquire	50	z-plans)	were	selected	here.	The	307 
frequency	of	acquisitions	is	one	XYZT	series	every	2	min	and	the	total	duration	is	30	min.	If	the	308 
	 	
set-up	is	not	fast	or	sensitive	enough,	it	is	possible	to	reduce	the	lateral	resolution	(down	to	512	309 
x	512)	or	the	number	of	z-slices	(by	imaging	exclusively	in	the	z-depth	which	exhibits	the	strongest	310 
fluorescence	[i.e.,	not	the	deepest	z-slices	where	fluorescence	is	faint]),	or	to	decrease	the	speed	311 
of	the	scanner.	The	axial	resolution	can	also	be	decreased	by	increasing	the	z-step	up	to	3	µm,	312 
but	as	this	may	impact	the	quantification,	all	experiments	to	be	compared	should	be	performed	313 
with	the	same	z-step.	314 
	315 
NOTE:	 It	 is	possible	 to	perform	similar	experiments	on	slices	 from	CX3CR1creER-YFP	mice18,	a	316 
mouse	line	used	to	induce	genetic	deletion	in	microglia	only,	and	in	which	microglia	constitutively	317 
express	 yellow	 fluorescent	 protein	 (YFP).	 However,	 the	 expression	 level	 of	 YFP	 is	 very	 low	318 
compared	to	green	fluorescent	protein	(GFP)	in	CX3CR1GFP/+	mice;	thus,	imaging	is	possible	but	319 
challenging	and	requires	the	optimization	of	the	acquisition	parameters.	It	is	recommended	to	320 
adjust	them	as	follows.	321 
	322 
4.1.5. Tune	 the	 laser	at	970	nm	 (which	 is	better	adapted	 to	YFP	excitation	 than	920	nm),	 the	323 
power	at	50%,	and	the	gain	at	50%,	which	corresponds	to	a	laser	power	under	the	objective	of	5	324 
-	6	mW.		325 
	326 
4.1.6. Set	a	line	average	of	4	(or	more)	to	improve	the	signal-to-noise	ratio.	327 
	328 
4.2. Positioning	 of	 the	 slice	 and	 of	 the	 glass	micropipette,	 and	 the	 local	 application	 of	 the	329 
compound	330 
	331 
4.2.1. Connect	 the	 peristaltic	 pump	 to	 the	 recording	 chamber,	 30	 min	 before	 starting	 the	332 
recording.	After	cleaning	the	whole	perfusion	system	with	50	mL	of	ultrapure	water,	start	 the	333 
perfusion	of	the	recording	chamber	with	aCSF	(50	mL)	contained	in	a	glass	beaker	under	constant	334 
carbogenation.	 Throughout	 the	 experiment,	 keep	 the	 circulating	 aCSF	 to	 32	 °C	with	 an	 inline	335 
microheater	or	a	Peltier	heater.	336 
	337 
NOTE:	A	specific	perfusion	chamber	with	top	and	bottom	perfusion	is	designed	to	optimize	the	338 
oxygenation	on	both	sides	of	the	slice.	The	perfusion	chamber	is	composed	of	two	perfectly	fitting	339 
parts,	with	a	polyamide	mesh	stretched	between	them	(Figure	2A,B).	Compared	with	other	types	340 
of	chambers,	where	the	slice	is	directly	laying	on	a	glass	coverslip,	this	chamber	reduces	neuronal	341 
death	in	the	bottom	part	of	the	slice,	improves	viability,	and	reduces	the	slice	movements	induced	342 
by	its	swelling.	343 
	344 
4.2.2. With	a	wide-mouth	disposable	transfer	pipette,	transfer	the	brain	slice	to	be	imaged	to	the	345 
aCSF	beaker	to	remove	the	lens	paper,	let	it	sink	(as	a	proof	that	no	air	bubble	is	attached),	and	346 
transfer	it	to	the	recording	(perfusion)	chamber.	347 
	348 
4.2.3. Position	a	slice	holder	(a	hairpin	made	of	platinum	with	the	two	branches	joined	by	parallel	349 
nylon	threads)	on	the	slice	to	minimize	slice	movement	due	to	the	perfusion	flow.	350 
	351 
	 	
4.2.4. Use	the	bright-field	illumination	to	target	the	brain	region	of	interest	(exposure	time:	50	to	352 
80	ms)	using	a	low	magnification	objective	(5X	or	10X).	Switch	to	the	higher	magnification	(25X	353 
with	a	0.35X	lens)	water	immersion	objective	and	adjust	the	position.	354 
	355 
NOTE:	Avoid	to	image	fields	close	to	the	slice	holder’s	nylon	threads	as	they	can	block	the	light	356 
and	locally	deform	the	slice.	Make	sure	that	the	area	of	interest	is	flat.	If	necessary,	remove	the	357 
slice	holder	in	order	to	reposition	the	slice	and/or	the	slice	holder.	358 
	359 
4.2.5. Use	the	fluorescence	illumination	to	locate	fluorescent	microglial	cells	to	be	imaged	in	the	360 
field	(exposure	time:	250	-	500	ms).	361 
	362 
NOTE:	This	step	allows	researchers	to	check	the	presence	of	cells	 in	the	region	of	interest	and	363 
their	fluorescence	intensity,	and	to	control	for	the	amount	of	cellular	debris.	364 
	365 
4.2.6. Backfill	the	pipette	with	10	µL	of	aCSF	with	ATP,	5-HT,	or	the	drug	of	 interest	at	 its	final	366 
concentration.	Point	the	tip	downward	and	gently	shake	the	drug-filled	pipette	to	remove	any	air	367 
bubbles	trapped	in	the	tip.	368 
	369 
NOTE:	If	the	solution	to	be	injected	tends	to	form	bubbles,	consider	using	borosilicate	pipettes	370 
with	an	internal	filament.	Leakage	of	ATP	out	of	the	pipette	can	attract	microglial	processes	even	371 
before	the	injection	(if	this	occurs,	it	will	be	visible	at	the	analysis	step).	Although	this	should	be	372 
moderate	with	the	ATP	concentration	used	(500	µmol·L-1),	if	it	is	an	issue,	consider	prefilling	the	373 
micropipette	with	2	mL	of	aCSF	prior	to	adding	the	ATP	(or	other	compound)	solution	at	step	374 
4.2.6.	375 
	376 
4.2.7. Mount	the	filled	pipette	in	a	pipette	holder,	connected	with	transparent	tubing	to	a	5	mL	377 
syringe,	with	a	plunger	positioned	at	the	5	mL	position.	The	pipette	holder	itself	is	mounted	onto	378 
a	three-axis	micromanipulator.	379 
	380 
4.2.8. Under	bright-field	 illumination,	use	 the	micromanipulator	 to	position	 the	pipette	 in	 the	381 
center	of	the	field.	For	a	reproducible	and	optimal	centering,	display	and	use	the	rulers	on	the	382 
image.	383 
	384 
4.2.9. Lower	the	pipette	gently	toward	the	slice,	controlling	and	adjusting	the	objective	at	the	385 
same	time,	until	the	pipette	tip	lightly	touches	the	surface	of	the	slice.	Stopping	the	descent	of	386 
the	 pipette	 as	 soon	 as	 it	 is	 visible	 that	 the	 slice	 has	 been	 touched	 allows	 the	 pipette	 tip	 to	387 
penetrate	80	-	100	µm	of	the	surface	of	the	slice	(see	Figure	3B).	388 
	389 
4.2.10. Tune	the	laser	(see	the	parameters	above)	and	switch	the	microscope	to	the	multiphoton	390 
mode.	Make	sure	that	the	chamber	is	screened	from	any	light	source	(e.g.,	a	computer	screen).	391 
Switch	on	the	nondescanned	detectors	and	set	the	gain.	Use	a	lookup	table	(LUT)	with	a	color-392 
coded	upper	limit	to	avoid	saturating	the	pixels	in	the	image.		393 
	394 
	 	
4.2.11. Determine	the	thickness	of	the	slice	to	be	imaged	(i.e.,	the	upper	and	lower	z-positions	395 
where	fluorescence	is	detectable	[usually	between	220	and	290	µm	in	total]).		396 
	397 
NOTE:	 At	 the	 surface	 of	 the	 slice,	 there	 is	 an	 increased	 density	 of	 processes	 and	 possibly	 of	398 
microglia,	often	with	an	unusual	morphology,	 in	 comparison	with	 the	 inside	of	 the	 slice.	 This	399 
accumulation	will	be	more	striking	with	time	(i.e.,	more	visible	in	the	last	than	in	the	first	brain	400 
slice	to	be	imaged).	Therefore,	the	z-planes	in	the	first ~30	µm	should	not	be	used	for	the	analysis	401 
and	can	even	be	skipped	for	the	acquisition.	402 
	403 
4.2.12. Start	 recording	 for	 a	 total	 duration	 of	 30	min	 (or	more	 if	 desired)	 and	 after	 a	 5	min	404 
baseline,	locally	apply	the	compound	to	be	tested	(without	interrupting	the	imaging).	To	do	this,	405 
slowly	press	the	plunger	of	the	syringe	connected	to	the	micropipette,	from	the	5	mL	to	the	1	mL	406 
position	(in	about	5	s).	Resistance	when	pressing	the	plunger	must	be	felt	immediately.	If	not,	the	407 
tip	might	be	broken.	408 
	409 
NOTE:	 For	 a	 trained	 experimenter,	 the	 injections	 with	 this	 method	 are	 reproducible,	 but	410 
alternatively	 to	 the	 manual	 manipulation	 of	 a	 syringe,	 the	 pipette	 could	 be	 linked	 to	 an	411 
automated	 pressure	 ejection	 system	 to	 allow	 a	 better	 control	 of	 the	 volume	 delivered.	 The	412 
injection	creates	a	physical	distortion	of	the	slice	at	the	site	of	the	 injection.	This	distortion	 is	413 
visible	a	posteriori	in	the	first	two	or	three	images	after	the	injection	but	should	not	be	visible	on	414 
the	fourth	image,	(i.e.,	8	min	after	the	injection).	If	it	persists,	consider	changing	the	parameters	415 
for	the	pipette	preparation.	416 
	417 
4.2.13. At	the	end	of	the	acquisition	(30	min),	discard	the	micropipette	and	remove	the	slice.	If	418 
desired,	 fix	 the	 slice	 for	 further	 immunolabeling.	 For	 example,	 the	 SNAPSHOT	 method	 is	419 
optimized	for	the	fixation	and	staining	of	thick	slices23.	420 
	421 
4.2.14. Prior	to	starting	to	image	a	new	slice,	make	the	2D	movie	(section	5.1)	in	order	to	check	422 
that	microglia	have	a	normal	morphology	and	are	moving	and,	thus,	that	the	slices	are	healthy.	423 
	424 
5. Analysis	of	the	Attraction	of	Microglial	Processes		425 
	426 
5.1. 2D	projection	and	drift	correction	427 
	428 
5.1.1. Open	the	file	(.LIF)	with	Fiji24.	429 
	430 
5.1.2. If	necessary,	make	a	substack	(Image/Stacks/Tools/Make	Substack)	with	only	the	z-planes	431 
of	 interest.	For	example,	exclude	the	z-planes	corresponding	to	the	surface	of	the	slice	 if	they	432 
have	been	acquired	but	are	not	to	be	used	for	the	analysis	(see	the	NOTE	after	step	4.2.11)	and	433 
the	deepest	z-planes	with	no	fluorescence.	The	final	stack	generally	contains	90	-	110	z-slices	(180	434 
-	220	µm).	435 
	436 
5.1.3. Launch	 the	 Z	 project	 function	 (Image/Stacks/Z	 Project")	 and	 select	 the	Max	 Intensity	437 
projection	type	to	make	the	projections	of	the	z-stack	acquired	at	each	time	point.	438 
	 	
	439 
5.1.4. Launch	the	MultiStackReg	plugin	(Plugin/Registration/MultiStackReg),	selecting	Action	1:	440 
Align	and	Transformation:	Rigid	Body	to	correct	slight	drifts	that	may	have	occurred	during	the	441 
acquisition.	Save	this	2D	movie	as	a	new	file	(.TIFF).	442 
	443 
5.2. Data	processing	444 
	445 
5.2.1. Open	this	new	file	with	Icy25.	446 
	447 
5.2.2. Draw	a	circular	R1	region	of	interest	(ROI)	of	35	µm	in	diameter,	centered	on	the	injection	448 
site	(identified	notably	by	the	shadow	of	the	pipette	and	the	distortion	created	at	the	time	of	449 
injection).		450 
	451 
5.2.3. Use	the	plugin	ROI	intensity	evolution	and	measure	the	mean	intensity	over	time	in	R1.	452 
	453 
5.2.4. Save	the	results	to	an	.XLS	file.	454 
	455 
5.3. Quantification	and	representation	of	the	results	456 
	457 
5.3.1. To	quantify	the	microglial	response	over	time,	determine	at	each	time	point		458 
	459 𝑅 𝑡 = 𝑅1 𝑡 − `𝑅1(0)
`𝑅1(0) 	461 
	460 
Here,`R1(0)	 is	 the	 mean	 of	 the	 R1(t)	 values	 before	 the	 injection.	 Then,	 the	 results	 can	 be	462 
represented	as	a	kinetic	of	the	microglial	response,	or	at	a	specific	time	point	(see	Figure	7).	463 
	464 
REPRESENTATIVE	RESULTS:	465 
This	 protocol	 describes	 a	 method	 to	 induce,	 observe,	 and	 quantify	 the	 oriented	 growth	 of	466 
microglial	processes	toward	a	locally	applied	compound,	for	example,	ATP	or	5-HT,	in	acute	brain	467 
slices	from	young	or	adult	(at	least	up	to	two-month-old)	mice.	Among	the	factors	that	contribute	468 
to	maintaining	brain	slices	from	adult	animals	in	a	healthy	state	for	several	hours	is	the	use	of	two	469 
tools	designed	to	optimize	cell	survival	at	two	steps	of	the	protocol.	First,	the	interface	slice	holder	470 
in	the	interface	chamber	(Figure	1)	improves	the	conservation	of	the	slices	after	cutting.	Second,	471 
the	recording	chamber	(Figure	2)	has	a	perfusion	system	which	allows	the	aCSF	to	run	both	at	the	472 
top	and	at	the	bottom	of	the	slice	during	imaging.	The	recording	chamber	dimensions	used	here	473 
are	set	to	fit	standard	microscopes	as	they	are	similar	to	classical	bath	chamber	inserts	(with	a	62	474 
mm	outer	diameter),	but	as	their	models	are	downloadable	from	the	Supplemental	Material,	the	475 
design	can	be	adapted	to	fit	in	slice	holders	of	other	dimensions.	To	note	is	that	each	chamber	is	476 
made	 by	 the	 assembly,	 without	 glue,	 of	 two	 perfectly	 fitting	 parts,	 with	 a	 polyamide	 mesh	477 
stretched	between	them.	478 
	479 
	 	
To	deliver	ATP	or	5-HT	in	a	small	area	and	induce	a	local	response	of	microglia,	a	pipette	containing	480 
the	 compound	 (visible	 in	 Figure	 2C,D)	 is	 placed	 with	 its	 tip	 on	 top	 of	 the	 slice.	 In	 the	 first	481 
experiments,	it	can	be	helpful	to	add	a	fluorescent	dye	to	the	solution,	in	order	to	visualize	the	482 
position	 of	 the	 pipette	 tip	 on	 the	 images	 that	 are	 acquired	with	 the	 two-photon	microscope	483 
(Figure	3A).	In	Figure	3B,	it	is	visible	that	although	the	experimenter	stopped	the	pipette	descent	484 
as	 soon	 as	 its	 tip	 touched	 and	 deformed	 the	 slice	 surface	 on	 the	 bright-field	 image	 of	 the	485 
computer	screen,	its	thin	extremity	entered	slightly	into	the	tissue,	down	to	80	-	100	µm	from	the	486 
surface.	 It	 is	 important	 that	 the	 pipette	 is	 not	 too	 superficial	 because	 it	may	 not	 deliver	 the	487 
solution	correctly	onto	the	cells,	nor	enter	too	deep	because	it	may	reach	a	region	where	the	488 
fluorescence	signal	is	too	low.	The	parameters	that	may	affect	the	depth	reached	by	the	pipette	489 
tip	are	the	angle	of	the	pipette,	which	can	be	adjusted	with	the	three-axis	micromanipulator,	and	490 
the	pipette	mouth	diameter.	491 
	492 
Note	 that,	with	 the	 projection	 along	 the	 Y-axis	 (Figure	 3B),	 it	 is	 possible	 to	 observe	 that	 the	493 
fluorescence	is	stronger	in	the	upper	than	in	the	lower	part	of	the	slice.	This	is	due	both	to	the	494 
progressive	blunting	of	the	signal	inside	the	slice	and	to	the	fact	that	processes	of	microglia	of	the	495 
superficial	 layers	of	 the	 slice,	 and	 some	cell	bodies,	 tend	 to	migrate	 toward	 the	 surface.	As	a	496 
result,	microglia	in	the	most	superficial	layers	of	the	slice	might	show	a	different	morphology	than	497 
those	inside	the	slice,	indicating	that	they	are	not	in	the	same	state,	and	may	react	differently	to	498 
stimulation.	Thus,	superficial	microglial	activation	may	mask,	in	the	z-projection,	the	response	of	499 
the	microglia	below.	In	addition,	the	surface	is	often	tilted,	and	the	first	z-images	of	the	stacks	are	500 
patchy.	Therefore,	we	recommend,	for	a	better	accuracy,	to	exclude	the	most	superficial	z-planes	501 
from	the	z-projection	and	analysis.	However,	as	altered	microglia	morphology	and	the	presence	502 
of	debris	in	the	superficial	layers	are	indicators	of	the	condition	of	the	slice,	it	can	be	interesting	503 
to	image	the	full	depth	of	a	slice	to	check	its	status	a	posteriori.	This	can	be	especially	useful	to	504 
new	experimenters	who	may	not	easily	 recognize	abnormal	microglia	or	debris	 from	single	 z-505 
planes.	The	z-planes	taken	in	the	first	30	µm	will	then	be	excluded	at	the	z-projection	step	(step	506 
5.1.2	of	the	protocol).	507 
	508 
Once	the	slice	has	been	treated	with	the	compound	of	 interest	and	recorded,	 the	series	of	z-509 
planes	(excluding	the	first	30	µm,	as	discussed	above)	imaged	at	each	time	point	are	projected	510 
along	 the	 z-axis	 to	make	 a	 2D	movie	 of	 z-projection	 images.	 To	 note	 is	 that	 in	 the	 protocol	511 
presented	here,	the	thickness	used	for	the	max	z-projection	encompasses	all	the	z-slices	where	512 
fluorescence	is	visible	(usually	180	-	220	µm,	see	step	5.1.2	of	the	protocol).	Therefore,	variations	513 
in	the	absolute	number	of	z-slices	do	not	impact	the	quantification	of	the	response.	In	contrast,	514 
some	 studies	use	 thinner	 z-stacks	 (40	 -	 60	µm)	 for	 z-projection6,7,11,27.	 This	 is	 another	option,	515 
which	comes	with	the	risk	to	exclude	some	z-slices	which	exhibit	a	response,	as	we	observed	that	516 
the	 attractant	 effect	 was	 visible	 as	 far	 as	 70	 µm	 (in	 z)	 away	 from	 the	 pipette	 tip	 in	 some	517 
experiments.	 If	 the	 thinner	option	 is	preferred,	 it	 is,	 thus,	critical	 to	center	 the	z-stack	on	 the	518 
pipette	 tip	 in	 z,	 and	 importantly,	 only	 z-projections	 done	 in	 the	 same	manner	 (i.e.,	 using	 all	519 
fluorescent	z-slices	or	using	a	thin	z-stack)	can	be	compared.	520 
	521 
An	R1	region	of	interest	is	then	defined	for	quantitative	analysis.	Figure	4	shows	an	ROI	on	a	z-522 
projection.	The	red	dashed	lines	represent	the	putative	position	of	the	pipette.	The	yellow	circle	523 
	 	
is	R1,	drawn	with	Icy,	and	centered	on	the	putative	tip	of	the	pipette.	Importantly,	we	observed	524 
that	a	noticeable	variability	arose	during	the	quantification	from	the	localization	of	the	R1	ROI,	525 
whose	misplacement	leads	to	an	underestimation	of	the	response.	To	help	positioning	the	ROI	526 
on	 the	site	of	delivery,	we	 recommend	displaying	 the	 rulers	 in	 the	acquisition	software	when	527 
positioning	 the	pipette	 in	 the	brightfield,	 in	order	 to	place	 the	pipette	 tip	always	 in	 the	same	528 
central	XY	position	in	the	field	to	be	imaged.	This	provides	an	indication	of	where	to	position,	529 
later,	the	ROI	in	the	Z-projection	of	the	fluorescence	images.	However,	the	final	tip	position	and,	530 
thus,	the	actual	site	of	delivery	will	be	slightly	shifted	from	this	central	position,	depending	on	531 
the	depth	reached	by	the	pipette	tip.	For	this	reason,	to	position	R1,	we	take	into	consideration	532 
three	other	criteria:	(i)	R1	must	be	at	the	tip	of	the	pipette,	the	position	of	which	is	inferred	from	533 
the	 dark	 background	 in	 the	 lower	 right	 corner,	 (ii)	 it	 should	 correspond	 to	 the	 area	where	 a	534 
transient	 distortion	 of	 the	 tissue	 occurs	 when	 the	 compound	 is	 injected,	 and	 (ii)	 it	 should	535 
correspond	to	the	area	where	a	local	response	(if	any)	is	observed.	If	this	is	not	sufficient	to	locate	536 
with	good	accuracy	the	point	of	delivery,	filling	the	pipette	with	a	fluorescent	compound	will	help.	537 
After	having	drawn	R1,	we	run	the	movie	again	to	check	that	it	is	well	positioned	for	all	the	time	538 
points	and	that	there	are	no	aberrant	drift,	distortion,	or	artifact	fluorescence	at	any	time	point,	539 
which	could	bias	 the	quantification.	The	movie	corresponding	 to	Figure	4,	and	 illustrating	 the	540 
effect	of	ATP	application,	can	be	found	in	the	supplemental	material	(Movie	S1).		541 
	542 
We	initially	studied	the	attraction	of	microglial	processes	toward	ATP	or	5-HT	in	the	thalamus	of	543 
P11	mice15.	More	 recently,	 these	experiments	were	 repeated	 in	 slices	 from	 four-day-	 to	 two-544 
month-old	mice,	and	in	various	regions	(for	example,	Figure	3	corresponds	to	a	recording	in	the	545 
hippocampus).	We	mostly	used	three-	to	four-week-old	mice,	which	combines	the	advantages	of	546 
having	 a	 mature	 brain—with	 mature	 and	 ramified	 microglia—with	 a	 good	 slice	 viability.	547 
Importantly,	 representative	 normal-state	 microglia	 are	 characterized	 by	 a	 small	 soma,	 long	548 
processes	 with	 small	 terminals,	 and	 constantly	 moving	 processes	 at	 the	 baseline	 condition.	549 
Typically,	 in	 slices	 from	 18-	 to	 30-day-old	 mice,	 the	 microglia	 morphology	 remains	 mostly	550 
unchanged	for	up	to	6	h	after	the	slice	preparation.	For	slices	from	older	mice	(two	months	old),	551 
the	ability	to	maintain	the	slices	in	a	physiological	state	is	reduced	(~4	h).	Examples	of	microglial	552 
direction	motility	in	the	thalamus,	in	response	to	5-HT	in	a	slice	from	a	20-day-old	mouse	and	to	553 
ATP	in	a	slice	from	a	two-month-old	mouse,	are	provided	in	Figure	5.	The	movie	corresponding	554 
to	the	5-HT	application	in	Figure	5	can	be	found	in	the	supplemental	material	(Movie	S2).	555 
	556 
Figure	6	presents	two	suboptimal	experiments	made	on	slices	kept	for	longer	than	6	h	in	aCSF	557 
before	they	were	imaged	(only	times	0	are	shown).	In	Figure	6A,	note	the	presence	of	microglia	558 
with	multiple	short	processes	or	with	enlarged	terminals	reminiscent	of	neurite	growth	cones,	559 
and	the	presence	of	many	fluorescent	cell	debris	or	particles.	These	very	fluorescent	elements	560 
stay	immobile	or	move	randomly	during	imaging,	indicating	that	they	do	not	belong	to	“living”	561 
microglia	(see	Movie	S3	in	the	supplemental	material).	To	note	is	that,	in	this	particular	example,	562 
microglia	were	constantly	scanning	their	environment,	but	their	morphology	was	so	altered	that	563 
they	could	not	be	considered	as	being	 in	a	physiological	state.	Moreover,	the	 large	amount	of	564 
debris	 would	 have	 made	 the	 fluorescence	 analysis	 poorly	 reliable.	 Figure	 6B	 illustrates	 the	565 
presence	of	microglia	with	 large	 and	 flat	 cell	 bodies	or	protrusions,	which	 can	 sometimes	be	566 
found	 on	 the	 superficial	 layers	 of	 slices	 that	 have	 been	 kept	 several	 hours	 before	 they	were	567 
	 	
imaged.	Only	 superficial	 z-positions	 have	 been	 used	 to	make	 this	 z-projection.	Figure	 6C	 is	 a	568 
substack,	at	deeper	z-positions,	from	the	same	brain	slice	as	shown	in	Figure	6B.	Although	they	569 
are	not	positioned	at	the	surface,	these	microglia	have	an	abnormal	“bushy”	aspect.	Due	to	the	570 
aspect	 of	 microglia,	 the	 movies	 corresponding	 to	 these	 two	 slices	 were	 not	 used	 for	571 
quantification.	572 
	573 
After	 extracting	 the	 data	 from	 the	 2D-movies,	 the	 results	 can	 be	 represented	 by	 plotting	574 
normalized	R(t)	fluorescence	over	time.	A	graph	summarizing	several	experiments	is	presented	in	575 
Figure	 7A,	 to	 show	 the	 variability	 of	 the	 responses.	 Note	 that	 the	 fluorescence	 decreases	576 
immediately	but	transiently	(in	the	first	three	images)	after	the	injection	due	to	tissue	distortion	577 
(i.e.,	the	liquid	injection	with	the	pipette	transiently	pushes	the	tissue	away,	and	then	increases).	578 
The	 variability	 in	 the	 response	 to	ATP	 illustrates	 the	 fact	 that	 even	when	 slices	 look	 similarly	579 
healthy,	with	motile	and	ramified	microglia,	they	do	not	respond	in	the	same	manner	(but	all	of	580 
them	do	respond).	On	top	of	intrinsic	sample	heterogeneity,	there	is	some	looseness	in	the	R1	581 
positioning,	 as	 mentioned	 above,	 and	 we	 also	 cannot	 exclude	 an	 impact	 of,	 for	 example,	582 
differences	in	the	volume	of	the	solution	which	is	delivered.	Therefore,	to	detect	small	effects	or	583 
variations,	it	may	be	interesting	to	use	an	automatic	device	for	the	compound	injection.	584 
	585 
Figure	7B	shows	how	the	size	of	the	ROI	also	impacts	the	quantification,	here	of	the	growth	of	586 
ATP-induced	processes.	Increasing	the	diameter	from	35	(the	diameter	used	in	Figure	7A	and	for	587 
all	the	analyses	presented	here)	to	50	or	70	µm	reduces	the	variability	among	experiments	(slices)	588 
by	suppressing	the	issue	of	the	small	R1	positioning.	However,	it	also	decreases	accuracy	and	the	589 
magnitude	of	the	detected	response.	Indeed,	with	larger	ROIs,	there	is	more	background	due	to	590 
processes	or	cell	bodies	not	affected	by	the	treatment,	and	a	growth	of	processes	can	be	partially	591 
blunted	by	the	concomitant	retraction	of	microglial	branches	more	distant	from	the	pipette	but	592 
nevertheless	inside	the	ROI.	In	conclusion,	it	can	be	relevant	to	use	ROIs	with	a	different	diameter	593 
circle	than	one	that	is	35	µm,	but	it	is	fundamental	that	the	ROI	is	always	the	same	in	all	the	data	594 
sets	to	be	compared.	595 
	596 
Figure	7C	shows	the	mean	±	SEM	for	several	experiments	with	aCSF,	ATP,	or	5-HT.	The	effect	of	597 
ATP	is	in	the	same	range	as	those	obtained	by	other	groups	with	a	similar	method	 in	vivo	(0.5	598 
according	to	Davalos	et	al.3	and	0.4	according	to	Haynes	et	al.13)	and	in	slices	(0.8	if	normalized	599 
as	is	done	here,	according	to	Dissing-Olesen	et	al.5,	and	0.6	according	to	Pagani	et	al.28).	On	the	600 
one	 hand,	 differences	 can	 come	 from	 biological	 parameters,	 such	 as	 the	 slice	 preparation	601 
method,	the	amount	of	ATP	injected,	the	age	of	the	mouse,	or	the	brain	region	used,	and	on	the	602 
other	hand	from	analysis	parameters,	such	as	the	diameter	of	the	ROI	and	the	thickness	of	the	z-603 
stacks	used	for	the	z-projection	(i.e.,	the	whole	thickness	where	fluorescence	is	detected,	or	only	604 
the	40	-	60	µm	around	the	pipette	tip,	where	the	maximal	response	is	expected).		605 
	606 
In	Figure	7C,	the	aCSF	injection	is	the	negative	control,	necessary	to	check	that	the	local	injection	607 
and	the	pressure	of	the	pipette	do	not	cause	an	injury	that	may	attract	microglial	processes.	In	608 
addition,	the	aCSF	control	allows	researchers	to	check	that	there	is	no	photobleaching	over	time.	609 
Indeed,	 photobleaching,	 the	 photon-induced	 destruction	 of	 the	 fluorescent	 proteins	 or	610 
fluorophores,	would	have	induced	a	progressive	decrease	of	fluorescence	over	time.	As	it	can	bias	611 
	 	
measurements,	 it	 is	 important	 to	 rigorously	 check	 that	 there	 is	 no	 photobleaching	 in	 the	612 
experimental	conditions.	To	do	this,	it	is	recommended	to	acquire	an	XYZT	series	on	a	slice	with	613 
GFP-expressing	 microglia,	 for	 30	 min	 (aCSF	 can	 be	 injected	 but,	 actually,	 no	 stimulation	 is	614 
needed),	with	the	excitation	and	acquisition	parameters	set	as	in	the	experimental	conditions.	615 
Then,	 a	 quantitative	 measure	 of	 the	 fluorescence	 over	 time	 in	 different	 regions	 of	 interest,	616 
including	microglia	 cell	 bodies	 or	 processes,	 will	 reveal	 if	 there	 is	 a	 gradual	 loss	 in	 emission	617 
intensity,	 usually	 an	 exponential	 decay,	 indicating	 photobleaching.	 If	 this	 is	 the	 case,	 some	618 
adjustments	can	be	performed:	a	realignment	of	the	laser,	a	reduction	of	the	laser	power	and	an	619 
increase	of	 the	detector	 gain,	 a	 reduction	of	 the	number	of	 z-planes,	 and	 an	 increase	of	 the	620 
interval	between	them	to	limit	illumination.	Photobleaching	is	favored	by	high-power	or	long	(ex:	621 
repeated	illumination	for	line	averaging)	excitation;	thus,	researchers	must	pay	attention	to	it	if	a	622 
sustained	illumination	is	used	to	image	cells	with	low	fluorescence.	623 
	624 
After	the	local	injection	of	ATP	or	5-HT,	there	is	an	increase	of	fluorescence	in	R1,	which	reaches	625 
a	plateau	(Figure	7C).	In	addition	to	kinetics,	it	can	be	interesting	to	compare	the	attraction	at	a	626 
stable	endpoint.	Here,	we	chose	to	represent	the	microglial	response	at	t	=	26	min	(i.e.,	20	min	627 
after	the	injection)	in	Figure	7D.	This	is	useful	to	statistically	compare	compounds,	or	to	test	the	628 
effect	of	antagonists	which	can	be	added	in	the	bath	(i.e.,	in	the	perfusion	solution,	or	together	629 
with	the	compound	in	the	pipette	[not	shown]).		630 
	631 
FIGURE	LEGENDS:	632 
	633 
Figure	 1:	 Interface	 chamber	 details.	 (A)	 Outline	 for	 the	 3D	 printing	 of	 the	 slice	 holder.	 The	634 
external	diameter	of	the	holder	is	7	cm.	(B)	Interface	slice	holder	with	the	nylon	mesh	(arrow)	635 
that	allows	researchers	to	keep	slices	at	the	liquid-air	interface.	(C)	Interface	chamber	device	that	636 
makes	 it	possible	 to	maintain	 the	slices	 in	a	carbogenated	 (the	arrow	 indicates	 the	 tubing	 for	637 
bubbling)	and	humidified	environment	before	they	are	imaged.	638 
	639 
Figure	2:	Perfusion	chamber	details.	(A)	Outline	for	the	3D	printing.	The	external	diameter	of	the	640 
perfusion	 chamber	 is	 5.9	 cm.	 (B)	 The	 perfusion	 chamber	 with	 the	 nylon	 mesh	 (arrow)	 that	641 
supports	the	slice,	prevents	it	from	touching	the	slide	below,	and	allows	the	aCSF	to	flow	above	642 
and	under	it.	(C)	Picture	of	the	assembly	at	the	two-photon	microscope.	The	micropipette	which	643 
will	deliver	the	compound	locally	is	visible	on	the	right	(asterisk).	(D)	Pipette	imaged	in	brightfield.	644 
The	scale	bar	=	60	µm.	645 
	646 
Figure	3:	Position	of	the	micropipette	in	the	slice.	Example	of	an	acquisition	of	a	stack	of	images	647 
(in	the	hippocampus	of	a	30-day-old	animal)	with	a	micropipette	filled	with	fluorescein	(1	µM).	648 
Fluorescein	makes	it	possible	to	locate	the	pipette	(asterisk)	in	the	max	projections	along	(A)	the	649 
z-axis	 or	 (B)	 the	 y-axis.	Note	 in	 panel	B	 that,	 although	 fainter	 in	 fluorescence,	 there	 are	 also	650 
microglia	below	the	pipette	tip.	 In	this	 illustrated	example,	the	full	stack,	 including	the	images	651 
taken	in	the	most	superficial	part	of	the	slice,	has	been	used	for	the	projections.	The	scale	bar	=	652 
30	µm	in	panel	A	and	as	indicated	(each	graduation	=	50	µm)	in	panel	B.	The	z-thickness	of	the	653 
stack	=	220	µm.	654 
	655 
	 	
Figure	4:	Positioning	of	R1,	the	ROI	used	for	quantification.	This	figure	shows	three	experimental	656 
time	points	of	an	experiment	where	ATP	has	been	applied	on	a	slice	(from	the	thalamus	of	a	20-657 
day-old	animal),	with	drawings	of	the	putative	location	of	the	pipette	(red	dashed	line	on	the	first	658 
time	point)	and	the	delineation	of	the	R1	ROI.	The	scale	bar	=	30	µm.	Note	the	darker	area	in	the	659 
lower	right	corner,	corresponding	to	the	shade	of	the	pipette,	which	interferes	with	illumination	660 
and	imaging.	Note,	also,	the	small	region	of	intense	fluorescence	at	25	min,	which	indicates	the	661 
location	of	the	pipette	tip.	The	z-thickness	of	the	stack	=	220	µm.	662 
	663 
Figure	5:	Microglial	responses.	Responses	to	the	local	application	of	5-HT	(5	µM)	on	a	brain	slice	664 
from	a	20-day-old	mouse	(left;	the	slice	z-thickness	=	220	µm)	and	of	ATP	(500	µM)	on	a	slice	from	665 
a	two-month-old	mouse	(right;	the	slice	z-thickness	=	220	µm).	The	red	dashed	lines	represent	666 
the	pipette	position.	Both	recordings	have	been	done	in	the	thalamus,	and	the	upper	30	µm	of	667 
the	slices	have	been	excluded.	The	images	are	taken	before	(upper	row)	and	25	min	after	(lower	668 
row)	the	injection.	The	scale	bar	=	30	µm.	669 
	670 
Figure	6:	Examples	of	suboptimal	experiments.	These	slices	have	waited	for	more	than	6	h	before	671 
imaging	and	have	been	imaged	since	their	upper	surface.	(A)	Example	of	a	z-stack	with	a	lot	of	672 
debris	 (roughly	round,	 fluorescent	particles,	but	with	 irregular	borders;	asterisks)	and	“bushy”	673 
microglia	 (arrows),	 that	 is,	 with	 numerous	 but	 short	 processes.	 Note	 the	 enlarged	 process	674 
terminals	(arrowheads)	which	look	like	axonal	growth	cones.	The	z-thickness	of	the	stack	=	220	675 
µm.	 The	 other	 two	 panels	 show	 two	 sub-stacks	 of	 the	 same	 slice,	with	 (B)	 1-30	 z-planes	 (z-676 
thickness	=	59	µm)	and	(C)	30-120	z-planes	(z-thickness	=	180	µm).	On	the	top	planes	(shown	in	677 
panel	B),	in	addition	to	the	large	process	terminals	and	debris	like	in	panel	A,	there	are	microglia	678 
with	unusual	large	flat	bodies	or	protrusions	(stars).	On	the	deeper	planes	(shown	in	panel	C),	679 
there	is	no	debris	nor	flat	objects,	but	the	cells	are	bushy	(arrows)	and	the	density	is	unusually	680 
high.	Altogether,	these	observations	indicate	that	the	microglia	are	not	in	a	normal	state.	681 
	682 
Figure	 7:	Quantification	of	 the	 attraction	of	microglial	 processes.	 (A)	 Example	 of	 a	 series	 of	683 
experiments	with	ATP	to	illustrate	variability.	(B)	Impact	of	the	ROI	size	on	the	quantification.	Each	684 
experiment	shown	in	panel	A	(ATP	injection)	has	been	analyzed	with	an	ROI	of	35,	50,	or	70	µm	685 
diameter.	The	mean	±	SEM	of	the	fluorescence	at	each	time	point	is	shown	for	the	different	ROIs.	686 
(C)	Summary	of	experiments	with	aCSF,	5-HT,	and	ATP.	The	aCSF	injection	has	no	effect	on	the	687 
location	of	microglial	processes.	ATP	and	5-HT	induce	a	localized	growth	of	microglial	processes	688 
toward	 the	 pipette,	measured	 with	 the	 local	 increase	 of	 fluorescence.	 The	mean	 ±	 SEM	 are	689 
indicated.	 (D)	 Summary	of	microglial	 responses	 at	 t	 =	 20	min	postinjection	 (26	min	 from	 the	690 
beginning	of	recording).	The	mean	±	SEM	are	indicated.	One-way	ANOVA	with	Dunnett	post	hoc	691 
test	is	used.	**	p	<	0.01,	***	p	<	0.001	compared	to	the	aCSF	injection.	For	aCSF,	n	=	7;	for	ATP,	n	692 
=	8;	for	5-HT,	n	=	6.	All	these	experiments	were	performed	in	the	thalamus,	but	similar	results	can	693 
be	obtained	from	the	hippocampus	or	cortex.	The	z-thickness	of	the	stacks	used	for	z-projections	694 
and	quantification	=	180	-	220	µm.	All	measures	except	those	in	panel	B	have	been	done	with	a	695 
35	µm-diameter	ROI.	696 
	697 
Movie	S1:	Example	of	the	effect	of	a	local	ATP	(500	µM)	application.	This	experiment	has	been	698 
performed	in	the	thalamus	of	a	20-day-old	animal.	Images	from	this	movie	have	been	used	for	699 
	 	
Figure	4.	The	scale	bar	=	30	µm.	700 
	701 
Movie	S2:	Example	of	the	effect	of	a	local	5-HT	(5	µM)	application.	This	experiment	has	been	702 
performed	in	the	thalamus	of	a	20-day-old	animal.	Images	from	this	movie	have	been	used	for	703 
Figure	5	(left).	The	scale	bar	=	30	µm.	704 
	705 
Movie	S3:	Example	of	a	suboptimal	experiment	in	a	slice	having	waited	for	more	than	6	h	before	706 
imaging.	 Note	 the	 presence	 of	 numerous	 debris	 which	 moves	 randomly	 over	 time	 and	 the	707 
unusual	morphology	of	the	microglia.	An	image	from	this	movie	is	used	as	Figure	6A.	The	scale	708 
bar	=	30	µm.	709 
	710 
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	712 
DISCUSSION:	713 
By	maintaining,	unlike	in	dissociated	or	organotypic	slice	culture,	a	structural	integrity	with	limited	714 
network	adjustments,	acute	brain	slices	allow	researchers	to	study	microglia	in	their	physiological	715 
environment.	However,	one	of	the	major	limitations	is	the	fact	that	the	slicing	procedure	creates	716 
injuries	that	can	rapidly	compromise	the	viability	of	neurons,	particularly	in	the	adult	brain.	As	717 
microglia	are	particularly	reactive	to	cell	damage,	it	is	important	to	limit	neuronal	cell	death	as	718 
much	as	possible	to	preserve	microglia	close	to	their	physiological	state.	This,	in	turn,	contributes	719 
via	a	virtuous	circle	to	a	better	general	condition	of	the	slice.	720 
	721 
The	protocol	described	in	this	article	applies	several	 improvements	found	in	the	 literature	for	722 
electrophysiology	experiments,	aimed	at	obtaining	a	better	viability	of	 the	 slices	over	 several	723 
hours,	especially	 from	adult	mice.	To	overcome	 the	age-related	disparity	 in	 slice	viability,	we	724 
substituted	sodium	with	choline	and	used	this	choline-aCSF	medium	during	the	cardiac	perfusion,	725 
slicing,	and	recovery	phases.	This	brings	the	cell	excitotoxicity	to	a	minimum29,30.	 It	should	be	726 
noted	that,	in	addition	to	choline-aCSF,	there	are	many	other	alternative	aCSF	recipes	that	are	727 
highly	 effective	 for	 neuronal	 preservation,	 like	 N-methyl-D-glucamine	 (NMDG)-aCSF31,	 which	728 
could	also	be	interesting	for	microglial	studies	but	have	not	been	tested	here.	Another	critical	729 
step	in	this	procedure	is	the	cardiac	perfusion.	By	perfusing	the	animal	with	a	cold	choline-aCSF	730 
solution,	containing	low	Na+,	low	Ca2+,	and	high	Mg2+,	a	rapid	decrease	in	body	temperature	is	731 
induced	 and	 the	metabolic	 activity	 of	 the	 cells	 in	 the	 brain	 is	 lowered,	 thereby	 reducing	 the	732 
cellular	 stress	 caused	 by	 the	 cutting.	 Indeed,	 we	 observed	 that	 this	 approach	 offered	 more	733 
protection	than	simply	removing	the	whole	brain	and	submerging	it	in	aCSF	solution.	Inspired	by	734 
a	 protocol	 optimized	 for	 patch-clamp	 and	 optogenetic	 studies29,	 we	 also	 used	 a	 “protective	735 
recovery”	period	immediately	following	the	physical	slicing,	allowing	the	slices	to	recover	from	736 
the	trauma	of	slicing	for	10	min	in	choline-aCSF	at	32	°C.	Afterward,	slices	were	transferred	into	737 
the	interface	holding	chamber	to	recover	for	an	additional	minimum	time	of	30	min.	The	duration	738 
of	this	second	recovery	period	could	be	optimized	according	to	the	brain	area	of	interest,	the	Na+	739 
substitute,	and	the	age	of	the	animal,	and	it	should	last	at	least	1	h	if	electrophysiology	has	to	be	740 
performed	in	parallel	with	imaging.	741 
	742 
The	maintenance	of	the	slice	in	a	healthy	state	before	use	and	the	perfusion	during	imaging	are	743 
	 	
also	 important	 parameters.	 Both	 the	 interface	 and	 the	 dual-perfusion	 chamber	 are	 widely	744 
established	 tools	 in	 electrophysiology.	 For	 example,	 the	 interface	 method	 has	 been	 used	 to	745 
improve	the	viability	of	hippocampal	slices	since	199526.	Devices	similar	to	the	chambers	used	746 
here	are	proposed	by	several	companies	but	not	yet	commonly	used	for	microglia	imaging.	We	747 
designed	an	interface	holding	chamber,	where	the	slices	lay	on	a	net	and	are	on	the	interface	with	748 
a	 large	 reservoir	 of	 aCSF,	 delaying	 the	 cellular	 deterioration	 of	 the	 slices	 during	 prolonged	749 
incubation	times.	In	the	imaging	chamber,	we	used	a	designed	double-sided	perfusion	chamber	750 
which	allows	increased	oxygenation	of	acute	slice	preparations,	maintaining	the	cells	in	a	healthy	751 
state	during	multiphoton	microscopy.	In	contrast	with	the	single	perfusion,	the	double	perfusion	752 
of	submerged	slices	increases	the	viability	of	the	cells,	since	oxygen,	as	well	as	other	materials,	753 
can	freely	and	effectively	diffuse	with	a	high	flow	rate	from	both	sides	of	considerably	thick	slices.		754 
	755 
This	protocol	is	aimed	at	quantifying	the	global	attractant	effect	of	ATP	or	other	compounds	on	756 
microglial	processes,	and	its	quantification	method	is	based	on	the	one	used	in	Davalos	et	al.3.	It	757 
is	possible	to	perform	other	kinds	of	analysis.	For	example,	an	alternative	method,	which	does	758 
not	depend	on	the	fluorescence	level	of	the	microglial	processes	but	requires	more	actions	of	the	759 
experimenter	for	the	image	analysis,	is	to	measure	the	reduction	of	the	empty	space	around	the	760 
pipette	tip	after	compound	application11,32.	It	is	also	possible	to	track	the	movement	of	the	tip	of	761 
individual	microglial	processes15,28.		762 
	763 
In	 addition,	 the	 isotropic	motility	 or	 surveillance	 of	microglia	 can	 also	 be	 registered	 in	 basal	764 
condition	or	upon	the	bath	application	of	compounds	of	interest	on	the	slices	prepared	with	this	765 
protocol.	However,	to	quantify	the	fast	extension	and	retraction	rates	of	microglial	processes	and	766 
detect	 potential	 variations,	 it	 would	 be	 relevant	 to	 increase	 the	 acquisition	 frequency.	 For	767 
example,	Pagani	et	al.	use	a	frequency	of	one	image	every	10	s28.		768 
	769 
Finally,	recent	publications	described	methods	to	quantify	morphological	changes	or	the	motility	770 
of	individual	processes	in	three	dimensions.	For	such	analyses,	although	a	z-step	interval	of	2	µm	771 
is	enough	for	some	programs27,	others	require	a	better	axial	resolution	(i.e.,	a	z-step	of	0.4	µm	772 
according	to	Heindl	et	al.33.	773 
	774 
Here,	 we	 showed	 experiments	 on	 wild-type	 mice	 with	 an	 endogenous	 expression	 of	 GFP	 in	775 
microglia	and	with	a	mechanical	application	of	compounds,	but	this	protocol	can	be	adapted	to	776 
other	 fluorescent	 reporter	 proteins	 in	 microglia,	 like	 YFP18,	 or	 to	 the	 exogenous	 labeling	 of	777 
microglia	 with	 fluorescent	 isolectin11,34.	 Finally,	 we	 have	 studied	 the	 outgrowth	 of	 microglial	778 
processes	toward	a	local	application	of	ATP	or	5-HT	in	a	wild-type	normal	environment,	but	this	779 
protocol	 could	 be	 used	 to	 test	 other	 compounds,	 other	 kinds	 of	 stimulation	 (e.g.,	 caged	780 
compounds),	 and	 to	 test	 how	 directional	 motility	 is	 affected	 by	 mutations,	 pharmacological	781 
agents,	or	pathological	contexts.	782 
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